Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 117,984,795
- Total 13F value
- $1,259,732,308
- Share change
- +6,328,611
- Put/Call ratio
- 41%
- SEC-reported price per share
- $10.65
- Number of holders
- 160
- Value change
- +$77,596,210
- Number of buys
- 107
- Number of sells
- 46
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
160
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00288U106
Recent filing periods:
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital World Investors
Disclosed value leader
Capital World Investors
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 6%
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors leads the comparable SEC ownership view at 6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Comparable ownership
Top 5
Capital World Investors
6%
Allianz Asset Management GmbH
3.7%
BAILLIE GIFFORD & CO
3.6%
BAKER BROS. ADVISORS LP
3.4%
SB Management Ltd
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital World Investors |
13F
Company
|
6%
|
$178,111,000
18,267,775 shares
|
— | 31 Mar 2022 |
| Allianz Asset Management GmbH |
13F
Company
|
3.7%
|
$108,791,000
11,158,045 shares
|
— | 31 Mar 2022 |
| BAILLIE GIFFORD & CO |
13F
Company
|
3.6%
|
$107,725,000
11,048,765 shares
|
— | 31 Mar 2022 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
3.4%
|
$101,889,000
10,450,180 shares
|
— | 31 Mar 2022 |
| SB Management Ltd |
13F
Company
|
2.5%
|
$75,702,000
7,764,299 shares
|
— | 31 Mar 2022 |
| DCVC Bio GP, LLC |
13F
Company
|
2.4%
|
$71,231,000
7,305,761 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
160
Shares
117,984,795
Rows available
160
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
126
Q2 2022 holders
160
Holder diff
34
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend